rongsheng wang in stock

Happy Holidays from the Wang Lab! We concluded 2022 with some high school outreach -playing with the enzymes & fluorescent probes with students and answering questions related to STEM careers & college life including that. And finally today here is a holiday party!

Rongsheng (Ross) Wang, assistant professor of chemistry, has earned a five-year, $700,000 award from the National Science Foundation (NSF) to develop medicinal chemistry-aided imaging techniques of cell components that could lead to faster diagnosis of diseases such as cancer and inflammatory disorders.

"We are utilizing a medicinal chemistry approach to invent chemical imaging agents that can selectively recognize targeted HDACs," said Wang. "This class of imaging probes will provide us with unique cell biology information regarding the location of the histone deacetylases in the cell and distribution of the enzymes in and between organelles, components that help keep the cell alive and functioning."

Changes to the organelle could play a big role in identifying those diseases and the progression of the disease in the organelles, explained Wang. "These probes could be ideal diagnostic tools for human diseases such as cancer, inflammation, aged neuron degeneration, and auto-immune disorders."

The imaging probes can be used for real-time cellular screening of additional small molecule inhibitors that can inhibit the HDACs" enzyme activity," said Wang, whose previous research projects involved studying breast and prostate cancer. "Alternatively, without imaging units, they by themselves could be potentially therapeutics too if they can inhibit the HDACs in the long run."

There is also a strong educational and STEM outreach plan associated with the award. "We"ll work with students from schools near Temple, demonstrating the use of fluorescent small molecule probes," said Wang, who, since joining the Department of Chemistry faculty in 2016, has hosted several science events for students from local high schools in Philadelphia. "We really like impacting and educating high school students."

Wang"s lab was also among nine winning teams in the final year of Scialog: Chemical Machinery of the Cell, launched in 2018 to spark collaborative research that could advance fundamental understanding of chemical machinery and reactions in the intact cell. Short for "science + dialog," Scialog is funded by Research Corporation for Science Advancement and the Gordon and Betty Moore Foundation.

HONG KONG (Reuters) - Shares in China Rongsheng Heavy Industries Group Holdings Ltdtumbled 18 percent on Monday after the U.S. securities regulator accused a company controlled by the shipbuilder"s chairman of insider trading ahead of China"s CNOOC Ltd"sbid for Canadian oil company Nexen Inc.Labourers work at a Rongsheng Heavy Industries shipyard in Nantong, Jiangsu province May 21, 2012. REUTERS/Aly Song

The U.S. Securities and Exchange Commission filed a complaint in a U.S. court on Friday against a company controlled by Rongsheng Chairman Zhang Zhirong, and other traders, accusing them of making more than $13 million from insider trading ahead of CNOOC’s $15.1 billion bid for Nexen.

On Monday, Rongsheng shares dropped as much as 18 percent to HK$1.15, a record low, leaving the company with a market capitalization of just over $1 billion. The company also issued a profit warning, saying first-half earnings would fall sharply as a result of a global shipbuilding downturn, a factor that has already pushed its shares down more than 75 percent in the past year.

Rongsheng - which entered a strategic cooperation agreement with CNOOC in 2010 - said in a Hong Kong filing that it did not expect the U.S. investigation to affect its operations. It said Zhang did not have an executive role in the company.

“The news around the chairman comes on the back of other operational and credibility issues,” Barclays said in a note to clients. “We think China Rongsheng presents significant company-specific risk.”

Zhang was ranked the 22th richest Chinese person by Forbes Magazine in September 2011. But his net worth fell by more than half in the past year to $2.6 billion in March 2012 as shares of Rongsheng tumbled.

SHANGHAI, March 5 (Reuters) - China Rongsheng said it had scrapped a warrant issue that would have given the heavily indebted shipbuilder a HK$3 billion ($416 million) cash lifeline after it was unable to contact the offer’s only subscriber.

Rongsheng’s shares fell as much as 8.1 percent in early Thursday trade, after it said it would no longer issue HK$510 million worth of warrants to Kingwin Victory Investment Ltd, a Cayman Islands-incorporated investment firm.

In a stock exchange filing, Rongsheng said it had scrapped the issue as it could not contact Kingwin’s owner Wang Ping after media reports said he had been detained by the Beijing police for matters not related to Rongsheng.

“The company has no information as to the details of the incident and has been unable to contact Mr. Wang Ping, which casts doubt over the ability of the subscriber to perform its obligations,” Rongsheng said.

On Wednesday, Chinese news magazine Caixin reported that Beijing police had detained Wang on Feb. 23 over financial irregularities in investments made by Cypress Capital Group, another firm that he chaired.

Rongsheng, one of China’s largest shipbuilders, was gearing to move into oil exploration and change its name after becoming one of the most prolific casualties of the global shipping slump. It came close to insolvency in 2013 before agreeing with banks to extend its loans until the end of this year.

The warrant issue that Rongsheng had agreed with Kingwin in October would have entitled subscribers to buy up to 1.7 billion new shares at HK$1.60 each.

This would have raised about HK$3.23 billion for Rongsheng, the firm said at the time. A warrant entitles the holder to buy stock from the issuer at a specific price within a time frame. ($1 = 7.7552 Hong Kong dollars) (Reporting by Brenda Goh; Editing by Miral Fahmy)

The Board is pleased to announce that the English name of the Company has been changed from "China Rongsheng Heavy Industries Group Holdings Limited" to "China Huarong Energy Company Limited" and the Chinese name of the Company has been changed from

The stock short name of shares of the Company for trading on the Stock Exchange will be changed from "CH RONGSHENG" to "HUARONG ENERGY" in English and from "中國 熔盛重工" to "華榮能源" in Chinese with effect from 9:00 a.m. on 24 April 2015. The stock

Reference is made to the announcement of China Huarong Energy Company Limited (formerly known as China Rongsheng Heavy Industries Group Holdings Limited) (the "Company") dated 29 October 2014 and the circular of the Company dated 17 February

The Board is pleased to announce that the English name of the Company has been changed from "China Rongsheng Heavy Industries Group Holdings Limited" to "China Huarong Energy Company Limited" and the Chinese name of the Company has been changed from

The stock short name of shares of the Company for trading on the Stock Exchange will be changed from"CH RONGSHENG" to "HUARONG ENERGY" in English and from "中國熔 盛重工" to "華榮能源" in Chinese with effect from 9:00 a.m. on 24 April 2015. The stock

Rongsheng Petro Chemical Co, Ltd. specialises in the production and marketing of petrochemical and chemical fibres. Products include PTA yarns, fully drawn polyester yarns (FDY), pre-oriented polyester yarns (POY), polyester textured drawn yarns (DTY), polyester filaments and polyethylene terephthalate (PET) slivers.

Glitch in Rongsheng Rescue Sheds Light on Shady Investor;Capital market veteran Wang Ping had sights set on struggling shipbuilder, but has been detained on fraud charges

(Beijing) – The detention by police of a capital market veteran has interrupted the restructuring plans of China’s largest private shipbuilder and shed light on the tricks used by an investor who seems to have always profited from distressed companies. In early March, debt-ridden shipbuilder Rongsheng Heavy Industries Group Holdings cancelled a planned 3 billion yuan warrant issuance to the private equity firm Kingwin Victory Investment Ltd.Behind the cancelled deal is the detention of Wang Ping, the controller of Kingwin Victory and chairman of Cypress & Kingwin Capital Group Ltd. Sources close to the matter said Wang was arrested on February 23 in Zhuhai, in the southern province of Guangdong, by police from Beijing on charges of fraud in investment funds.

Wang has been an active player in stock market and PE sector over the past several years. His Cypress & Kingwin Capital serves as an umbrella for a number of equity investment funds and Wang has sat on the boards of more than a dozen companies listed on the mainland and in Hong Kong.

Wang is seen as a kind of vulture investor in China’s capital market – he usually buys assets from distressed sellers at a low cost and profits from reselling the assets after restructuring.

Before his latest target, Wang had purchased the country’s largest building materials chain, Oriental Home; software developer named 35.com; and Walmart’s Chinese partner, SZITIC Commercial Property Co. Many investors said Wang’s investments did not bail these companies, but were in fact questionable transactions with opaque capital flows.

Wang’s detention follows an investigation into Jiang Yuemin, chairman of Oriental Home and president of Cypress & Kingwin Capital in May 2014. A person close to Wang said he has been in Hong Kong for most of the past year. When he returned to Zhuhai for Spring Festival, he was detained.

Wang, who in his 40s, is a native of the northeastern province of Jilin. He once worked for a major state-owned company in the coastal city of Xiamen, and then started an equity investment business.

In February 2012, Wang’s Cypress & Kingwin Capital signed an agreement with Liu Hui, chairman of ARC Capital Holdings, to take over the latter’s 65 percent stake in Oriental Home, which operates 25 large building materials markets across the country but was suffering from a shortage of capital.

In October, Kingwin Victory Investment, which is wholly owned by Wang, agreed with Rongsheng to buy 1.7 million of the latter’s newly issued shares. After the issuance, Kingwin Victory would become Rongsheng’s largest shareholder, with a 19.2 percent stake.

Zhang Zhirong, Rongsheng’s founder and largest shareholder, said the deal would provide the company with 3 billion yuan to support a business transformation to the energy industry.

Wang started to tap the shipping market in late 2012, despite a global slowdown. In December that year, Cypress & Kingwin Capital signed an agreement with the government of Zhoushan, in the eastern province of Zhejiang, to set up a 10 billion yuan shipping industry fund. In September 2013, the fund completed its first batch fundraising, totaling 508 million yuan.

In May last year, Wang’s Kingwin Capital Group purchased HK$ 1 billion worth of convertible bonds from Hong Kong-listed China Ocean Shipbuilding Industry Group. If the bonds are converted, Wang would become China Ocean Shipbuilding’s controlling shareholder, with a 49.4 percent stake.

Rongsheng scheduled a March 13 shareholder meeting to vote on Kingwin Victory’s investment. But on March 4, following media reports that Wang had been detained, the company filed a statement with Hong Kong’s stock exchange announcing the deal had been cancelled.

In late March, Rongsheng said in a statement that it had signed an agreement on a reshuffle involving a partner, but did not elaborate. It also said it had decided to sell all its shipbuilding assets and focus on energy.

People familiar with Wang said he made a fortune from investments in small and new start-up businesses listed in Shenzhen. In 2008 and 2009, a Cypress & Kingwin Capital investment subsidiary purchased 2.9 million shares of Shenzhen Changhong Technology Co. and quadrupled its investment after Changhong went public a year later.

Sources close to Wang said that since the dispute with Oriental Home escalated, Wang started to sell his stakes in Cypress & Kingwin Capital’s subsidiaries. In October, he reduced his 72 percent holding in Zhongke Hongyi Venture Capital Co., the major asset of Cypress & Kingwin Capital, to 10.7 percent and stepped down as its chairman and legal representative.